ADGM SCHEDULE 13G/A: SEC filing

Perceptive Advisors LLC and related reporting persons

Filed with the SEC on · accession 0001193125-26-463801

ADGM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -16.6% by the first close after the filing.

Summary of the filing

Perceptive Advisors LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 44.4% of Adagio Medical Holdings' common stock, including shares underlying warrants and director options.

Key details

Shares of common stock beneficially owned by Perceptive Advisors LLC$523K
Shares of common stock beneficially owned by Joseph Edelman$523K
Shares of common stock beneficially owned by Perceptive Life Sciences Master Fund, Ltd.$517K
Shares of common stock beneficially owned by C2 Life Sciences LLC$7K
Shares of common stock outstanding as of November 11, 2026$983K
Shares underlying warrants held by reporting persons$182K
IssuerAdagio Medical Holdings, Inc.
Reporting person / investment managerPerceptive Advisors LLC
Reporting person / record holderPerceptive Life Sciences Master Fund, Ltd.
Reporting person / record holderC2 Life Sciences LLC
Managing member of perceptive advisors llcJoseph Edelman
Managing director at perceptive advisors; board member of adagio medicalKeyvan Mirsaeedi-Farahani
Managing director at perceptive advisors; board member of adagio medicalOrly Mishan

How ADGM stock reacted

Close before

$1.93

Nov 13, 2026

First close after

-16.58%

$1.61

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ADGM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ADGM?

Click here

Frequently asked questions

What did ADGM file with the SEC on Nov 16, 2026?

ADGM filed a SCHEDULE 13G/A (SEC filing). Perceptive Advisors LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 44.4% of Adagio Medical Holdings' common stock, including shares underlying warrants and director options.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ADGM stock react to this filing?

ADGM closed at $1.93 before the filing and $1.61 on Nov 16, 2026 (-16.58%).

Other ADGM SEC filings

Get alerts when ADGM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days